ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,090.27
      0.00%
      US Tech 100
      21,030.00
      -0.14%
      Dow Jones
      44,642.52
      0.00%
      Brent Oil
      72.06
      1.33%
      Bitcoin
      99,110.44
      -2.10%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Impact Biomedical Inc (IBO) Quote

      Impact Biomedical Inc

      Impact Biomedical Inc (IBO)

      Universal Ibogaine Inc
      2.14
      -0.14
      (-6.14%)
      Closed December 06 4:00PM
      Delayed by 15 minutes
      1.97
      -0.17
      ( -7.94% )
      Pre Market: 8:42AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.97
      Bid
      -
      Ask
      -
      Volume
      253
      0.00 Day's Range 0.00
      1.22 52 Week Range 3.25
      Previous Close
      2.14
      Open
      -
      Last Trade
      250
      @
      1.97
      (formt)
      Last Trade Time
      08:42:55
      Average Volume (3m)
      87,605
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      IBO Latest News

      More News

      Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

      HOUSTON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      November 19 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 04 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

      HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

      October 15 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      October 08 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

      HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

      October 07 2024
      GlobeNewswire Inc.

      Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

      HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

      September 26 2024
      GlobeNewswire Inc.

      Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

      NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

      September 23 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 17 2024
      Edgar (US Regulatory)

      Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

      NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) --  Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

      September 17 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.92-31.83391003462.892.941.97376192.38491462CS
      4-1.23-38.43753.23.251.97488812.71329186CS
      12-1.03-34.333333333333.251.22876052.30371188CS
      26-1.03-34.333333333333.251.22876052.30371188CS
      52-1.03-34.333333333333.251.22876052.30371188CS
      156-1.03-34.333333333333.251.22876052.30371188CS
      260-1.03-34.333333333333.251.22876052.30371188CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      YINNDirexion Daily FTSE China Bull 3X Shares
      $ 34.90
      (20.30%)
      		5.49M
      OPTTOcean Power Technologies Inc
      $ 0.3969
      (16.56%)
      		3.42M
      AUSTAustin Gold Corp
      $ 1.80
      (16.13%)
      		110
      CWEBDirexion Daily Csi China Internet Index Bull 2x Shares
      $ 41.20
      (15.93%)
      		174.86k
      UAMYUnited States Antimony Corp
      $ 2.17
      (14.21%)
      		1.02M
      YANGDirexion Daily FTSE China Bear 3X Shares New
      $ 60.32
      (-20.37%)
      		706.34k
      AUMNGolden Minerals Co
      $ 0.2199
      (-18.31%)
      		120.99k
      CHROChannel Therapeutics Corporation
      $ 0.723
      (-13.40%)
      		9.52k
      FXPProShares UltraShort FTSE China 50
      $ 16.45
      (-12.77%)
      		5.38k
      UXIProShares Ultra Industrials
      $ 36.00
      (-12.37%)
      		166
      MSTZT Rex 2X Inverse MSTR Daily Target ETF
      $ 0.9757
      (2.40%)
      		22.04M
      YINNDirexion Daily FTSE China Bull 3X Shares
      $ 34.90
      (20.30%)
      		5.49M
      FXIiShares China Large Cap
      $ 32.88
      (6.86%)
      		5.46M
      ETHU2x Ether ETF
      $ 11.26
      (-8.68%)
      		4.9M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 29.22
      (-1.32%)
      		3.58M

      IBO Discussion

      View Posts
      Disquisition Disquisition 2 months ago
      INCREDIBLE DUMPING
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      IBO...BOTTOM BOUNCER
      👍️0
      rizah rizah 2 years ago
      All resolutions were approved by the required majority of shareholders at Universal Ibogaine Inc.'s (IBO)annual general meeting ("AGM"), which was held on October 3, 2022 in Vancouver, British Columbia. The company is a life sciences company with a mission to provide medicalized ibogaine-centered addiction care.
      👍️0
      harry_brat harry_brat 2 years ago
      $IBO held on to its renowned capital market advisor

      UI recently announced that it has retained Mr. Shayne Nyquvest as their capital market advisor in a consulting role. Mr. Nyquvest has substantial capital markets experience, having assisted companies in the mining, cannabis, and other growing industries with strategic fund-raising initiatives for over 4 decades.
      👍️0
      Blue_Digital_Media Blue_Digital_Media 2 years ago
      Universal Ibogaine Inc. thanks to David for his contributions to the Company during his tenure as a Director.

      Watch now IBO for latest stock information.
      👍️0

      Your Recent History

      AMEX
      IBO
      Impact Biomedical
      Delayed Upgrade Clock